{"slug":"researchers","open_questions":[{"id":"open_question-db850ec9-5aeb-4af0-89b5-ef317452e948","title":"How can Pain, Clinical research signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-38d8ff7a-a645-4ab9-ab21-78c8ceb6346b","title":"How can Amyloid, APP processing signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-90996af6-0869-48fc-8122-d8ff9de9feba","title":"How can Vascular cognitive impairment signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-cae3f33d-c521-41eb-a129-de88719231be","title":"How can Biomarkers, Amyloid, Prevention signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-819f992d-4971-496f-bbbd-124c8684e555","title":"How can Single-Cell Genomics, Spatial Transcriptomics, Cell Types signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-46fe4d77-2fcd-422e-9a61-7b7531e8204c","title":"How can Clinical trials, Care research signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-ca5050ef-f2cd-4968-bbf5-50c7fd974397","title":"What trial designs can most efficiently translate mechanistic findings in Alzheimer's Disease and Cognitive decline into clinically meaningful interventions?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-226982ca-c66f-4ac0-b279-4f7a4edbdd73","title":"How can Risk factors, Prevention, Sleep signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-282550ae-fc58-4729-8c1d-45b72c153918","title":"What trial designs can most efficiently translate mechanistic findings in Neuropsychiatric Disorders and Alzheimer Disease into clinically meaningful interventions?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-785a6f7d-7295-43d6-816a-c72e9228b610","title":"How can Prevention, Biomarkers signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-1c31c230-fe91-4108-b222-975fcb96b1ff","title":"How can Funding, Research programs signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-f529ef72-0481-41e6-a91d-189ca5c75ac4","title":"How can Gamma-secretase, APP processing, Drug discovery signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-642754e6-5f66-4f8a-a2c6-efaa408bca05","title":"How can Clinical trials, Biomarkers signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-e6053212-8778-41da-8e75-7c6c3b830e2f","title":"What trial designs can most efficiently translate mechanistic findings in Parkinson's Disease into clinically meaningful interventions?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-b5c44514-dc37-4102-ac01-bb685ee7f01c","title":"Which biomarker combinations best separate causal mechanism activity from downstream epiphenomena?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-1cce1a08-8b69-4240-a24c-0cb2b2a0fd8e","title":"How can Genetics, Epidemiology signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-bb6b3e04-5fea-4555-9f0c-2581dd7779cf","title":"How can Cholinergic, Neurotrophic factors signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-eea99adc-ceb4-4828-a042-1b21d791a777","title":"How can Epigenetics, Histone deacetylases, Memory signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-1e7219dd-18fa-48c5-a553-f68779330551","title":"How can Sleep, Memory consolidation signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-269af2f1-696a-4b61-aecf-824b5a1574fe","title":"How can Epidemiology signals be standardized across cohorts and sites without losing disease-stage sensitivity?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5}],"open_questions_total":20,"knowledge_gaps":[],"gap_count":0,"landscape":null,"hypothesis_count":0,"personas":[{"id":"christof-koch","name":"Christof Koch","type":"debater","icon":"🌀","color":"#5c6bc0","debate_count":1},{"id":"rui-costa","name":"Rui Costa","type":"debater","icon":"🏃","color":"#ef5350","debate_count":1},{"id":"xiaojun-li","name":"Xiaojun Li","type":"debater","icon":"🔬","color":"#8d6e63","debate_count":0},{"id":"pete-skene","name":"Pete Skene","type":"debater","icon":"🔬","color":"#8d6e63","debate_count":0},{"id":"ed-lein","name":"Ed Lein","type":"debater","icon":"🧠","color":"#4fc3f7","debate_count":0},{"id":"clinical_trialist","name":"Clinical Trialist","type":"reviewer","icon":"📋","color":"#4dd0e1","debate_count":0},{"id":"sud-pinglay","name":"Sud Pinglay","type":"debater","icon":"🧬","color":"#26a69a","debate_count":0},{"id":"jay-shendure","name":"Jay Shendure","type":"debater","icon":"🧪","color":"#ffa726","debate_count":0},{"id":"medicinal_chemist","name":"Medicinal Chemist","type":"builder","icon":"🧪","color":"#aed581","debate_count":0}]}